Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-15

Clinical Trial Update: Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the efficacy and safety of Vigadexa for post-cataract surgery inflammation and infection, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigadexa (moxifloxacin/dexamethasone ophthalmic suspension)

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 4 | Status: COMPLETED | Results posted: 2010-02-15